# Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran

> **NCT00757679** · PHASE2 · COMPLETED · sponsor: **Pierre Fabre Medicament** · enrollment: 153 (actual)

## Conditions studied

- Fibromyalgia Syndrome

## Interventions

- **DRUG:** Milnacipran
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00757679
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2013-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00757679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00757679, "Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00757679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*